0001209191-19-055615.txt : 20191107
0001209191-19-055615.hdr.sgml : 20191107
20191107124515
ACCESSION NUMBER: 0001209191-19-055615
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191106
FILED AS OF DATE: 20191107
DATE AS OF CHANGE: 20191107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Andriole Michael T.
CENTRAL INDEX KEY: 0001698751
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35867
FILM NUMBER: 191199308
MAIL ADDRESS:
STREET 1: C/O ENDOCYTE, INC.
STREET 2: 3000 KENT AVENUE, SUITE A1-100
CITY: WEST LAFAYETTE
STATE: IN
ZIP: 47906
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHIMERIX INC
CENTRAL INDEX KEY: 0001117480
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330903395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27713
BUSINESS PHONE: 919.806.1074
MAIL ADDRESS:
STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27713
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-11-06
0
0001117480
CHIMERIX INC
CMRX
0001698751
Andriole Michael T.
2505 MERIDIAN PARKWAY, SUITE 100
DURHAM
NC
27713
0
1
0
0
Chief Business Officer
Common Stock
2019-11-06
4
P
0
100000
1.56
A
100000
D
The price reported in Column 4 is weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.525 to $1.60, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
/s/ Michael Alrutz, Attorney-In-Fact
2019-11-06